Dr Miaomiao Liu is an NHMRC Emerging Leadership Fellow and an ECR Research Leader at the Institute for Biomedicine and Glycomics. She obtained a joint PhD degree in 2017 from Griffith University and the University of Chinese Academy of Sciences. She has a career total of 52 research outputs including 49 peer- reviewed publications ,1 book chapter and 2 patent applications in the field of native MS, natural product chemistry and metabolomics. Dr Liu has attracted >$4.15M in research funding ($1.34 M as CIA and $1.2M as CIB) including two fellowships (NHMRC EL1 Investigator Fellowship (2024- 2028); Japan Society for the Promotion of Science (JSPS) Fellowship, 2022-2023) and a commercial project with big pharma industry partner Genentech (CIB, 2019 – 2021). Her multidisciplinary research program rests on three pillars: 1. Target identification by native mass spectrometry to identify the molecular target of bioactive molecules without the need to derivatise the molecule. 2. Characterising of ternary complex formed between a target protein, a PROteolysis Targeting Chimera (PROTAC) and an E3-ubqiutin ligase by native mass spectrometry. 3. Natural products chemistry by combining phenotypic-based drug discovery and target-based drug discovery to identify active compounds from natural resources.